182 related articles for article (PubMed ID: 29897440)
1. The Effect of Antibiotic Selection Pressure on the Nasopharyngeal Macrolide Resistome: A Cluster-randomized Trial.
Keenan JD; Chin SA; Amza A; Kadri B; Nassirou B; Cevallos V; Cotter SY; Zhou Z; West SK; Bailey RL; Porco TC; Lietman TM;
Clin Infect Dis; 2018 Nov; 67(11):1736-1742. PubMed ID: 29897440
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial.
Skalet AH; Cevallos V; Ayele B; Gebre T; Zhou Z; Jorgensen JH; Zerihun M; Habte D; Assefa Y; Emerson PM; Gaynor BD; Porco TC; Lietman TM; Keenan JD
PLoS Med; 2010 Dec; 7(12):e1000377. PubMed ID: 21179434
[TBL] [Abstract][Full Text] [Related]
3. Short-term increase in prevalence of nasopharyngeal carriage of macrolide-resistant Staphylococcus aureus following mass drug administration with azithromycin for trachoma control.
Bojang E; Jafali J; Perreten V; Hart J; Harding-Esch EM; Sillah A; Mabey DC; Holland MJ; Bailey RL; Roca A; Burr SE
BMC Microbiol; 2017 Mar; 17(1):75. PubMed ID: 28351345
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of nasopharyngeal
Hart JD; Samikwa L; Meleke H; Burr SE; Cornick J; Kalua K; Bailey RL
Lancet Microbe; 2022 Feb; 3(2):e142-e150. PubMed ID: 35156069
[TBL] [Abstract][Full Text] [Related]
5. Topical ocular antibiotics induce bacterial resistance at extraocular sites.
Gaynor BD; Chidambaram JD; Cevallos V; Miao Y; Miller K; Jha HC; Bhatta RC; Chaudhary JS; Osaki Holm S; Whitcher JP; Holbrook KA; Fry AM; Lietman TM
Br J Ophthalmol; 2005 Sep; 89(9):1097-9. PubMed ID: 16113356
[TBL] [Abstract][Full Text] [Related]
6. Mass distribution of azithromycin for trachoma control is associated with increased risk of azithromycin-resistant Streptococcus pneumoniae carriage in young children 6 months after treatment.
Coles CL; Mabula K; Seidman JC; Levens J; Mkocha H; Munoz B; Mfinanga SG; West S
Clin Infect Dis; 2013 Jun; 56(11):1519-26. PubMed ID: 23487375
[TBL] [Abstract][Full Text] [Related]
7. Prolonged mass azithromycin distributions and macrolide resistance determinants among preschool children in Niger: A sub-study of a cluster-randomized trial (MORDOR).
Arzika AM; Abdou A; Maliki R; Beido N; Kadri B; Harouna AN; Galo AN; Alio MK; Lebas E; Oldenburg CE; O'Brien KS; Chen C; Zhong L; Zhou Z; Yan D; Hinterwirth A; Keenan JD; Porco TC; Lietman TM; Doan T;
PLoS Med; 2024 May; 21(5):e1004386. PubMed ID: 38709718
[TBL] [Abstract][Full Text] [Related]
8. Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma.
Melese M; Alemayehu W; Lakew T; Yi E; House J; Chidambaram JD; Zhou Z; Cevallos V; Ray K; Hong KC; Porco TC; Phan I; Zaidi A; Gaynor BD; Whitcher JP; Lietman TM
JAMA; 2008 Feb; 299(7):778-84. PubMed ID: 18285589
[TBL] [Abstract][Full Text] [Related]
9. Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).
Keenan JD; Tadesse Z; Gebresillasie S; Shiferaw A; Zerihun M; Emerson PM; Callahan K; Cotter SY; Stoller NE; Porco TC; Oldenburg CE; Lietman TM
PLoS Med; 2018 Aug; 15(8):e1002633. PubMed ID: 30106956
[TBL] [Abstract][Full Text] [Related]
10. Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year.
Gaynor BD; Holbrook KA; Whitcher JP; Holm SO; Jha HC; Chaudhary JS; Bhatta RC; Lietman T
Br J Ophthalmol; 2003 Feb; 87(2):147-8. PubMed ID: 12543738
[TBL] [Abstract][Full Text] [Related]
11. A Cluster-Randomized Trial to Assess the Efficacy of Targeting Trachoma Treatment to Children.
Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; Zhou Z; Bailey RL; Mabey DC; Porco TC; Keenan JD; Gaynor BD; West SK; Lietman TM
Clin Infect Dis; 2017 Mar; 64(6):743-750. PubMed ID: 27956455
[TBL] [Abstract][Full Text] [Related]
12. Biannual Treatment of Preschool Children with Single Dose Azithromycin to Reduce Mortality: Impact on Azithromycin Resistance in the MORDOR Trial in Tanzania.
Bloch EM; Coles CL; Kasubi M; Weaver J; Mrango Z; Munoz B; Lietman TM; West SK
Am J Trop Med Hyg; 2020 Sep; 103(3):1301-1307. PubMed ID: 32067633
[TBL] [Abstract][Full Text] [Related]
13. Childhood Mortality After Mass Distribution of Azithromycin: A Secondary Analysis of the PRET Cluster-randomized Trial in Niger.
O'Brien KS; Cotter SY; Amza A; Kadri B; Nassirou B; Stoller NE; Zhou Z; West SK; Bailey RL; Keenan JD; Porco TC; Lietman TM
Pediatr Infect Dis J; 2018 Nov; 37(11):1082-1086. PubMed ID: 29561511
[TBL] [Abstract][Full Text] [Related]
14. Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo.
Hare KM; Grimwood K; Chang AB; Chatfield MD; Valery PC; Leach AJ; Smith-Vaughan HC; Morris PS; Byrnes CA; Torzillo PJ; Cheng AC
Eur J Clin Microbiol Infect Dis; 2015 Nov; 34(11):2275-85. PubMed ID: 26363637
[TBL] [Abstract][Full Text] [Related]
15. Impact of azithromycin administration for trachoma control on the carriage of antibiotic-resistant Streptococcus pneumoniae.
Batt SL; Charalambous BM; Solomon AW; Knirsch C; Massae PA; Safari S; Sam NE; Everett D; Mabey DC; Gillespie SH
Antimicrob Agents Chemother; 2003 Sep; 47(9):2765-9. PubMed ID: 12936971
[TBL] [Abstract][Full Text] [Related]
16. Mass administration of azithromycin and Streptococcus pneumoniae carriage: cross-sectional surveys in the Gambia.
Burr SE; Milne S; Jafali J; Bojang E; Rajasekhar M; Hart J; Harding-Esch EM; Holland MJ; Mabey DC; Sillah A; Bailey RL; Roca A
Bull World Health Organ; 2014 Jul; 92(7):490-8. PubMed ID: 25110374
[TBL] [Abstract][Full Text] [Related]
17. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial.
Porco TC; Gebre T; Ayele B; House J; Keenan J; Zhou Z; Hong KC; Stoller N; Ray KJ; Emerson P; Gaynor BD; Lietman TM
JAMA; 2009 Sep; 302(9):962-8. PubMed ID: 19724043
[TBL] [Abstract][Full Text] [Related]
18. Temporal Trends in Phenotypic Macrolide and Nonmacrolide Resistance for Streptococcus pneumoniae Nasopharyngeal Samples Up to 36 Months after Mass Azithromycin Administration in a Cluster-Randomized Trial in Niger.
Hazel A; Arzika AM; Abdou A; Lebas E; Porco TC; Maliki R; Doan T; Lietman TM; Keenan JD; Blumberg S
Am J Trop Med Hyg; 2023 Nov; 109(5):1107-1112. PubMed ID: 37783458
[TBL] [Abstract][Full Text] [Related]
19. Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR).
O'Brien KS; Arzika AM; Amza A; Maliki R; Ousmane S; Kadri B; Nassirou B; Mankara AK; Harouna AN; Colby E; Lebas E; Liu Z; Le V; Nguyen W; Keenan JD; Oldenburg CE; Porco TC; Doan T; Arnold BF; Lietman TM;
BMC Public Health; 2021 Apr; 21(1):822. PubMed ID: 33926403
[TBL] [Abstract][Full Text] [Related]
20. Effect of Biannual Mass Azithromycin Distributions to Preschool-Aged Children on Trachoma Prevalence in Niger: A Cluster Randomized Clinical Trial.
Arzika AM; Mindo-Panusis D; Abdou A; Kadri B; Nassirou B; Maliki R; Alsoudi AF; Zhang T; Cotter SY; Lebas E; O'Brien KS; Callahan EK; Bailey RL; West SK; Goodhew EB; Martin DL; Arnold BF; Porco TC; Lietman TM; Keenan JD;
JAMA Netw Open; 2022 Aug; 5(8):e2228244. PubMed ID: 35997979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
